Other Disorders

PAGE 7 of 10

View Table of Contents

Table 6. HTC Population Profile Patient Characteristics, Other Disorders, Data Reported from 1/1/2012 through 3/31/2023

HTC Population Profile Patient Characteristics, Other Disorders
Venous thromboembolism Blood coagulation
disorder without specific
diagnosis
Ehlers-Danlos syndrome
# (%) # (%) # (%)
# of patients 43391 (100) 2673 (100) 545 (100)
Age (years) <2 3430 (8) 118 (4) * *
2–10 3248 (7) 580 (22) 61 (11)
11–19 6629 (15) 838 (31) 215 (39)
20–44 10902 (25) 614 (23) 202 (37)
45–64 11450 (26) 302 (11) 55 (10)
65+ 7732 (18) 221 (8) * *
Sex Male 19330 (45) 831 (31) 104 (19)
Female 24061 (55) 1842 (69) 441 (81)
Ethnicity Hispanic, Latino/a, or Spanish origin 3924 (9) 605 (23) 28 (5)
Not Hispanic, Latino/a, or Spanish origin 37389 (86) 1930 (72) 489 (90)
Unknown 2078 (5) 138 (5) 28 (5)
Race American Indian/Alaska Native 219 (1) 40 (1) * *
Asian 837 (2) 83 (3) * *
Black or African American 7754 (18) 263 (10) 12 (2)
Native Hawaiian or other Pacific Islander 100 (0) 9 (0) * *
White 31745 (73) 2055 (77) 490 (90)
More than one of these 266 (1) 34 (1) * *
Unknown 2470 (6) 189 (7) 33 (6)
Insurance Status Insured 42642 (98) 2627 (98) 540 (99)
Uninsured 547 (1) 22 (1) * *
Unknown 202 (0) 24 (1) * *
History of HCV infection Yes * * 24 (1) * *
No * * 2161 (81) 389 (71)
Unknown * * 488 (18) * *
Not Applicable 43391 (100) 0 (0) 0 (0)
History of HIV infection Yes * * 18 (1) * *
No * * 2165 (81) 387 (71)
Unknown * * 490 (18) * *
Not Applicable 43391 (100) 0 (0) 0 (0)

† The HTC Population Profile contains 41 transgender individuals. For confidentiality purposes, the number of transgender patients is too small to report by year or other characteristics. Transgender patients have been included in the counts of male and female according to the sex assigned to them at birth since hemophilia and von Willebrand disease, the most common congenital bleeding disorders, affect the sexes differently.

* Counts greater than zero but less than five have been suppressed to protect patient confidentiality. Additional cells may be suppressed to prevent derivation of these counts by subtraction.

HCV and HIV status are not recorded for VTE patients.